7 Cathie Wood Stocks That Are Worth Buying in March

569
Comment
6

7 Cathie Wood Stocks That Are Worth Buying in March

InvestorPlace2022-03-11

ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

569

Report

Comment

rlgt
·2022-03-16
K
Reply
Like
Report
Machine23
·2022-03-13
Ok
Reply
3
Report
Liontrader
·2022-03-12
$UiPath(PATH)$Is definitely one to avoid. Trading new lows almost daily..
Reply
3
Report
Tailwind
·2022-03-12
🗼
Reply
3
Report
Jason81
·2022-03-12
Roku down so much
Reply
3
Report
BeBob
·2022-03-11
Like
Reply
3
Report
EverSys
·2022-03-11
gogogogo
Reply
1
Report
gachaboi123
·2022-03-11
Hii
Reply
2
Report
themonkey
·2022-03-11
Ok
Reply
3
Report
SMLim
·2022-03-11
Wow
Reply
3
Report
newcomer676
·2022-03-11
like
Reply
4
Report
Jliang
·2022-03-11
Please like
Reply
3
Report
Bryan_lyc
·2022-03-11
F
Reply
5
Report
sansCervelle
·2022-03-11
these are all promising stocks but it may take a few years to get substantial returns. meanwhile, the market is currently going through a correction, so theres a chance price may drop further.
Reply
5
Report
JayWin
·2022-03-11
Please reply and like, thanks
Reply
2
Report
Alexsj2021
·2022-03-11
Like pls
Reply
2
Report
Dennyeo
·2022-03-11
Yes
Reply
5
Report
Heidit
·2022-03-11
Nice
Reply
2
Report
Dave123
·2022-03-11
Up
Reply
4
Report
kcdc86
·2022-03-11
Like pls..
Reply
2
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1195233805?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-03-11 09:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195233805","market":"us","top_or_hot":-1,"title":"7 Cathie Wood Stocks That Are Worth Buying in March","media":"InvestorPlace","content":"<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VRTX","symbol_name":"福泰制药","start_time":0,"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","article_id":"1195233805","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","pubTimestamp":1646960442,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"VRTX":"福泰制药","U":"Unity Software Inc.","SPOT":"Spotify Technology S.A.","PATH":"UiPath","ROKU":"Roku Inc","TDOC":"Teladoc Health Inc.","MELI":"MercadoLibre"},"translate_title":"7 3月值得买入的凯西·伍德股票","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MELI":0.9,"PATH":0.9,"ROKU":0.9,"SPOT":0.9,"TDOC":0.9,"U":0.9,"VRTX":0.9},"content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":9032251892,"gmtCreate":1647390319618,"gmtModify":1676534223355,"author":{"id":"4093342164840720","authorId":"4093342164840720","name":"rlgt","avatar":"https://static.itradeup.com/news/58d2ace40c246b4d062d7966a2cb3d25","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9032251892","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036483336,"gmtCreate":1647181886805,"gmtModify":1676534200888,"author":{"id":"3574907279320575","authorId":"3574907279320575","name":"Machine23","avatar":"https://static.tigerbbs.com/4e7c812dbe184947690c36d45b6469be","vip":1,"crmLevel":6,"crmLevelSwitch":1},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036483336","repostId":1195233805,"repostType":2,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036609502,"gmtCreate":1647050940759,"gmtModify":1676534191735,"author":{"id":"3571354333795218","authorId":"3571354333795218","name":"Liontrader","avatar":"https://static.tigerbbs.com/f3bce732b9b3c7cbc33f190e2a9128b1","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"<a href=\"https://ttm.financial/S/PATH\">$UiPath(PATH)$</a>Is definitely one to avoid. Trading new lows almost daily..","listText":"<a href=\"https://ttm.financial/S/PATH\">$UiPath(PATH)$</a>Is definitely one to avoid. Trading new lows almost daily..","text":"$UiPath(PATH)$Is definitely one to avoid. Trading new lows almost daily..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036609502","repostId":1195233805,"repostType":2,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036812129,"gmtCreate":1647043142191,"gmtModify":1676534189814,"author":{"id":"3583705894030764","authorId":"3583705894030764","name":"Tailwind","avatar":"https://static.tigerbbs.com/e34622367968d3257c3ffe6b0d24ff87","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"🗼","listText":"🗼","text":"🗼","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036812129","repostId":1195233805,"repostType":2,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036813706,"gmtCreate":1647042799321,"gmtModify":1676534189737,"author":{"id":"4087757893647360","authorId":"4087757893647360","name":"Jason81","avatar":"https://community-static.tradeup.com/news/420dd8ffab866c5f303994d92c6570d4","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":1,"crmLevelSwitch":1},"htmlText":"Roku down so much","listText":"Roku down so much","text":"Roku down so much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036813706","repostId":1195233805,"repostType":2,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036381938,"gmtCreate":1646989346953,"gmtModify":1676534184866,"author":{"id":"3585307651801295","authorId":"3585307651801295","name":"BeBob","avatar":"https://static.tigerbbs.com/4c7fb1588c34a61b54c3059c16e50b4e","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036381938","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036381034,"gmtCreate":1646989345553,"gmtModify":1676534184841,"author":{"id":"3562717829058854","authorId":"3562717829058854","name":"EverSys","avatar":"https://static.tigerbbs.com/11a08d675c0a4f706a53d64244901417","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":5,"crmLevelSwitch":0},"htmlText":"gogogogo","listText":"gogogogo","text":"gogogogo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036381034","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036383721,"gmtCreate":1646989269966,"gmtModify":1676534184833,"author":{"id":"4087304258366280","authorId":"4087304258366280","name":"gachaboi123","avatar":"https://static.tigerbbs.com/cb83c17f0db9b4c88e80fb28cca1aab8","vip":1,"crmLevel":5,"crmLevelSwitch":1},"htmlText":"Hii","listText":"Hii","text":"Hii","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036383721","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036383810,"gmtCreate":1646989176967,"gmtModify":1676534184825,"author":{"id":"3573986430688942","authorId":"3573986430688942","name":"themonkey","avatar":"https://static.tigerbbs.com/573a67d390101884216129f5c49fe8a0","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036383810","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036389435,"gmtCreate":1646989060497,"gmtModify":1676534184811,"author":{"id":"3586259427226842","authorId":"3586259427226842","name":"SMLim","avatar":"https://static.tigerbbs.com/b84ccf92cfb9ec3d527d12880bb472db","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036389435","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036389974,"gmtCreate":1646988774337,"gmtModify":1676534184818,"author":{"id":"3582720098998598","authorId":"3582720098998598","name":"newcomer676","avatar":"https://static.tigerbbs.com/915835840baa58cd8ff045fc189b3a3f","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036389974","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036389020,"gmtCreate":1646988768580,"gmtModify":1676534184795,"author":{"id":"3578105588635717","authorId":"3578105588635717","name":"Jliang","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Please like","listText":"Please like","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036389020","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036380632,"gmtCreate":1646988708181,"gmtModify":1676534184779,"author":{"id":"3565920966285810","authorId":"3565920966285810","name":"Bryan_lyc","avatar":"https://static.tigerbbs.com/66a10601cf8b6aaa3feafd891bc9778e","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"F","listText":"F","text":"F","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036380632","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036380147,"gmtCreate":1646988578972,"gmtModify":1676534184772,"author":{"id":"3578716728895179","authorId":"3578716728895179","name":"sansCervelle","avatar":"https://community-static.tradeup.com/news/73bb75516984a660b4b1de5c464bb9c1","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"these are all promising stocks but it may take a few years to get substantial returns. meanwhile, the market is currently going through a correction, so theres a chance price may drop further.","listText":"these are all promising stocks but it may take a few years to get substantial returns. meanwhile, the market is currently going through a correction, so theres a chance price may drop further.","text":"these are all promising stocks but it may take a few years to get substantial returns. meanwhile, the market is currently going through a correction, so theres a chance price may drop further.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036380147","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036380313,"gmtCreate":1646988504187,"gmtModify":1676534184771,"author":{"id":"3581832598723204","authorId":"3581832598723204","name":"JayWin","avatar":"https://static.tigerbbs.com/e7fe632cbb77a4bc57ba97f59aeb8162","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Please reply and like, thanks&nbsp;","listText":"Please reply and like, thanks&nbsp;","text":"Please reply and like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036380313","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036317209,"gmtCreate":1646988388156,"gmtModify":1676534184787,"author":{"id":"3578806965809804","authorId":"3578806965809804","name":"Alexsj2021","avatar":"https://static.tigerbbs.com/118ce3f5ead4a1ff38f3cc0783c1ccbc","vip":1,"crmLevel":4,"crmLevelSwitch":1},"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036317209","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036317655,"gmtCreate":1646988370315,"gmtModify":1676534184756,"author":{"id":"3582021832486442","authorId":"3582021832486442","name":"Dennyeo","avatar":"https://static.tigerbbs.com/25b7d84fd64f134409a4350c85c88965","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036317655","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036317399,"gmtCreate":1646988252952,"gmtModify":1676534184763,"author":{"id":"3585567341976837","authorId":"3585567341976837","name":"Heidit","avatar":"https://static.tigerbbs.com/b15a14bcb1e7c71684448d84f3e500e7","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036317399","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036317082,"gmtCreate":1646988164468,"gmtModify":1676534184747,"author":{"id":"3573359276928522","authorId":"3573359276928522","name":"Dave123","avatar":"https://static.tigerbbs.com/efffe8dee569870cacb59635a243862c","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036317082","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9036315265,"gmtCreate":1646987750002,"gmtModify":1676534184708,"author":{"id":"3582248787663478","authorId":"3582248787663478","name":"kcdc86","avatar":"https://community-static.tradeup.com/news/cc68f682561b677ba318c1b85eb97dee","vip":1,"crmLevel":4,"crmLevelSwitch":1},"htmlText":"Like pls..&nbsp;","listText":"Like pls..&nbsp;","text":"Like pls..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036315265","repostId":1195233805,"repostType":4,"repost":{"id":"1195233805","pubTimestamp":1646960442,"share":"https://www.laohu8.com/m/news/1195233805?lang=&edition=full","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<html><head></head><body>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:<ul><li>Mercadolibre(NASDAQ:MELI)</li><li>Roku(NASDAQ:ROKU)</li><li>Spotify Technology(NYSE:SPOT)</li><li>Teladoc Health(NYSE:TDOC)</li><li>UiPath(NYSE:PATH)</li><li>Unity Software(NYSE:U)</li><li>Vertex Pharmaceuticals(NASDAQ:VRTX)</li></ul>Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&amp;D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.</body></html>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/>InvestorPlace</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","ROKU":"Roku Inc","U":"Unity Software Inc.","VRTX":"福泰制药","SPOT":"Spotify Technology S.A.","MELI":"MercadoLibre","PATH":"UiPath"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":569,"commentSize":0,"repostSize":0,"favoriteSize":6,"likeStatus":false,"favoriteStatus":false}}